NCT06332183View on ClinicalTrials.gov

GWAS and EWAS in Patients With Erdheim-Chester Disease

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

July 1, 2024

Study Completion Date

October 1, 2024

Conditions
Erdheim-Chester Disease
Interventions
GENETIC

Presence of polymorphisms

Statistical analysis of GWAS data, Genome-wide methylation pattern analysis, Integration of GWAS data and methylation data (meQTL analysis), Pathway enrichment analysis

Trial Locations (5)

Unknown

RECRUITING

Hopital Pitié Salpetrière, Paris

RECRUITING

Meyer Children's Hospital IRCCS, Florence

RECRUITING

IRCCS Ospedale San Raffaele, Milan

RECRUITING

AOU Parma, Parma

RECRUITING

Genetics Lab, CSIC, Granada

All Listed Sponsors
lead

Augusto Vaglio

OTHER